Discover open access scientific publications

Search, annotate, share and cite publications

Publications by Sarah N. Chatley

A First-In-Class TWIST1 Inhibitor With Activity in Oncogene-Driven Lung Cancer

Molecular Cancer Research

Cancer Research

Molecular Biology

English

Related publications

Integration of Stereotactic Body Radiation Therapy With Tyrosine Kinase Inhibitors in Stage IV Oncogene-Driven Lung Cancer

Cancer Research

English

When to Consider Immune Checkpoint Inhibitors in Oncogene-Driven Non-Small Cell Lung Cancer?

Current Treatment Options in Oncology

English

A Novel Imidazopyridine PI3K Inhibitor With Anticancer Activity in Non-Small Cell Lung Cancer Cells

Oncology Reports

Cancer Research

English

Amplifying Outcomes: Checkpoint Inhibitor Combinations in First‐Line Non‐Small Cell Lung Cancer

Cancer Research

English

P53-Suppressed Oncogene TET1 Prevents Cellular Aging in Lung Cancer

Cancer Research

Cancer Research

English

A Novel Dual PI3Kα/mTOR Inhibitor PI-103 With High Antitumor Activity in Non-Small Cell Lung Cancer Cells

International Journal of Molecular Medicine

English

Anti-Tumour Activity of a First-In-Class Agent NUC-1031 in Patients With Advanced Cancer: Results of a Phase I Study

British Journal of Cancer

Cancer Research

English

Genomic Profiling Identifies TITF1 as a Lineage-Specific Oncogene Amplified in Lung Cancer

Cancer Research

Molecular Biology

English

Methylation of the TWIST1 Promoter, TWIST1 mRNA Levels, and Immunohistochemical Expression of TWIST1 in Breast Cancer

Cancer Epidemiology Biomarkers and Prevention

English